Equine Performance Labs is dedicated to enhancing the health and performance of horses through its groundbreaking product, equicenta™ CTM. Developed in Austin, Texas, equicenta™ CTM is a next-generation injectable allograft derived from ethically sourced fetal equine umbilical cord tissue. This innovative solution prioritizes horse comfort and sports performance, offering optimal joint health and support for tendons and ligaments. Each application delivers over 2,400 natural proteins that facilitate rapid tissue repair and regeneration, making it a vital asset for veterinarians treating musculoskeletal conditions.

Equine Performance Labs boasts a rigorous, in-house processing method that ensures unmatched quality and transparency, setting it apart from other companies in the equine tissue market. Their commitment to safety is backed by extensive research, highlighting minimal adverse effects while achieving effective healing outcomes. Founded by horse enthusiasts, Equine Performance Labs embodies a deep passion for equine well-being, allowing every horse to receive the same quality of care as humans.